Asciminib is a potent kinase inhibitor indicated for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia (CML). As a specific ABL/BCR-ABL1 tyrosine kinase inhibitor, it functions… Read more











Asciminib is a potent kinase inhibitor indicated for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia (CML). As a specific ABL/BCR-ABL1 tyrosine kinase inhibitor, it functions by targeting the myristoyl pocket of the BCR-ABL1 protein, helping to manage resistant disease. This category provides a comprehensive selection of Asciminib reference standards, including pharmacopeial and non-pharmacopeial impurities, degradation products, and metabolites such as glucuronides. Pharmaceutical laboratories rely on these high-quality materials for impurity profiling, method validation, and rigorous quality control testing of the active pharmaceutical ingredient. To ensure precise quantification during bioanalytical studies and complex matrix analysis, the range also features stable isotope-labelled compounds, which serve as essential internal standards for accurate mass spectrometry measurements. Chemists and researchers use these materials to maintain regulatory compliance and support the integrity of analytical workflows throughout the drug development lifecycle.